| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | 0.16 | 9e-06 |
| mRNA | BRD-K86535717 | CTRPv2 | pan-cancer | AAC | 0.3 | 2e-05 |
| mRNA | BRD-K96970199 | CTRPv2 | pan-cancer | AAC | 0.28 | 6e-05 |
| mRNA | BRD-K07442505 | CTRPv2 | pan-cancer | AAC | 0.14 | 7e-05 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0001 |
| mRNA | BRD-K96431673 | CTRPv2 | pan-cancer | AAC | 0.26 | 0.0002 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0006 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0006 |
| mRNA | ML312 | CTRPv2 | pan-cancer | AAC | 0.23 | 0.0008 |
| mRNA | KIN001-270 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.001 |